ID   KAD2_RAT                Reviewed;         239 AA.
AC   P29410; Q6P7C6;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   24-JUL-2024, entry version 163.
DE   RecName: Full=Adenylate kinase 2, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03168};
DE            Short=AK 2 {ECO:0000255|HAMAP-Rule:MF_03168};
DE            EC=2.7.4.3 {ECO:0000255|HAMAP-Rule:MF_03168};
DE   AltName: Full=ATP-AMP transphosphorylase 2 {ECO:0000255|HAMAP-Rule:MF_03168};
DE   AltName: Full=ATP:AMP phosphotransferase {ECO:0000255|HAMAP-Rule:MF_03168};
DE   AltName: Full=Adenylate monophosphate kinase {ECO:0000255|HAMAP-Rule:MF_03168};
GN   Name=Ak2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8468325; DOI=10.1093/oxfordjournals.jbchem.a124026;
RA   Tanabe T., Yamada M., Noma T., Kajii T., Nakazawa A.;
RT   "Tissue-specific and developmentally regulated expression of the genes
RT   encoding adenylate kinase isozymes.";
RL   J. Biochem. 113:200-207(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Catalyzes the reversible transfer of the terminal phosphate
CC       group between ATP and AMP. Plays an important role in cellular energy
CC       homeostasis and in adenine nucleotide metabolism. Adenylate kinase
CC       activity is critical for regulation of the phosphate utilization and
CC       the AMP de novo biosynthesis pathways. Plays a key role in
CC       hematopoiesis. {ECO:0000255|HAMAP-Rule:MF_03168}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=AMP + ATP = 2 ADP; Xref=Rhea:RHEA:12973, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:456215, ChEBI:CHEBI:456216; EC=2.7.4.3;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03168};
CC   -!- SUBUNIT: Monomer. {ECO:0000255|HAMAP-Rule:MF_03168}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion intermembrane space
CC       {ECO:0000255|HAMAP-Rule:MF_03168}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P29410-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P29410-2; Sequence=VSP_036505;
CC   -!- DOMAIN: Consists of three domains, a large central CORE domain and two
CC       small peripheral domains, NMPbind and LID, which undergo movements
CC       during catalysis. The LID domain closes over the site of phosphoryl
CC       transfer upon ATP binding. Assembling and dissambling the active center
CC       during each catalytic cycle provides an effective means to prevent ATP
CC       hydrolysis. {ECO:0000255|HAMAP-Rule:MF_03168}.
CC   -!- SIMILARITY: Belongs to the adenylate kinase family. AK2 subfamily.
CC       {ECO:0000255|HAMAP-Rule:MF_03168}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D13061; BAA02378.1; -; mRNA.
DR   EMBL; BC061727; AAH61727.1; -; mRNA.
DR   PIR; JQ1944; JQ1944.
DR   RefSeq; NP_001029139.1; NM_001033967.2.
DR   AlphaFoldDB; P29410; -.
DR   SMR; P29410; -.
DR   STRING; 10116.ENSRNOP00000000134; -.
DR   BindingDB; P29410; -.
DR   ChEMBL; CHEMBL2376; -.
DR   DrugCentral; P29410; -.
DR   iPTMnet; P29410; -.
DR   PhosphoSitePlus; P29410; -.
DR   SwissPalm; P29410; -.
DR   jPOST; P29410; -.
DR   PaxDb; 10116-ENSRNOP00000000134; -.
DR   GeneID; 24184; -.
DR   KEGG; rno:24184; -.
DR   AGR; RGD:1562178; -.
DR   AGR; RGD:2077; -.
DR   CTD; 204; -.
DR   RGD; 2077; Ak2.
DR   eggNOG; KOG3078; Eukaryota.
DR   InParanoid; P29410; -.
DR   OrthoDB; 167111at2759; -.
DR   PhylomeDB; P29410; -.
DR   TreeFam; TF300896; -.
DR   Reactome; R-RNO-499943; Interconversion of nucleotide di- and triphosphates.
DR   PRO; PR:P29410; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005758; C:mitochondrial intermembrane space; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0036126; C:sperm flagellum; ISO:RGD.
DR   GO; GO:0097226; C:sperm mitochondrial sheath; ISO:RGD.
DR   GO; GO:0004017; F:adenylate kinase activity; IDA:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046083; P:adenine metabolic process; TAS:RGD.
DR   GO; GO:0006172; P:ADP biosynthetic process; IDA:RGD.
DR   GO; GO:0046033; P:AMP metabolic process; IDA:RGD.
DR   GO; GO:0046034; P:ATP metabolic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0046060; P:dATP metabolic process; IDA:RGD.
DR   GO; GO:0001889; P:liver development; IEP:RGD.
DR   GO; GO:0006119; P:oxidative phosphorylation; IEP:RGD.
DR   GO; GO:0097066; P:response to thyroid hormone; IEP:RGD.
DR   CDD; cd01428; ADK; 1.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   HAMAP; MF_00235; Adenylate_kinase_Adk; 1.
DR   HAMAP; MF_03168; Adenylate_kinase_AK2; 1.
DR   InterPro; IPR006259; Adenyl_kin_sub.
DR   InterPro; IPR000850; Adenylat/UMP-CMP_kin.
DR   InterPro; IPR033690; Adenylat_kinase_CS.
DR   InterPro; IPR007862; Adenylate_kinase_lid-dom.
DR   InterPro; IPR028587; AK2.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   NCBIfam; TIGR01351; adk; 1.
DR   PANTHER; PTHR23359:SF234; ADENYLATE KINASE 2, MITOCHONDRIAL; 1.
DR   PANTHER; PTHR23359; NUCLEOTIDE KINASE; 1.
DR   Pfam; PF00406; ADK; 1.
DR   Pfam; PF05191; ADK_lid; 1.
DR   PRINTS; PR00094; ADENYLTKNASE.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   PROSITE; PS00113; ADENYLATE_KINASE; 1.
PE   2: Evidence at transcript level;
KW   Acetylation; Alternative splicing; ATP-binding; Disulfide bond; Kinase;
KW   Mitochondrion; Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Transferase.
FT   CHAIN           1..239
FT                   /note="Adenylate kinase 2, mitochondrial"
FT                   /id="PRO_0000158920"
FT   REGION          45..74
FT                   /note="NMP"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03168"
FT   REGION          141..178
FT                   /note="LID"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03168"
FT   BINDING         25..30
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03168"
FT   BINDING         46
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03168"
FT   BINDING         51
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03168"
FT   BINDING         72..74
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03168"
FT   BINDING         100..103
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03168"
FT   BINDING         107
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03168"
FT   BINDING         142
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03168"
FT   BINDING         151..152
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03168"
FT   BINDING         175
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03168"
FT   BINDING         186
FT                   /ligand="AMP"
FT                   /ligand_id="ChEBI:CHEBI:456215"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03168"
FT   BINDING         214
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03168"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:P54819"
FT   MOD_RES         58
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P54819"
FT   MOD_RES         62
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WTP6"
FT   MOD_RES         91
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WTP6"
FT   MOD_RES         93
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WTP6"
FT   MOD_RES         133
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P54819"
FT   MOD_RES         181
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WTP6"
FT   MOD_RES         195
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P54819"
FT   DISULFID        42..92
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03168"
FT   VAR_SEQ         232..239
FT                   /note="CKDLVMFV -> S (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_036505"
FT   CONFLICT        14
FT                   /note="E -> K (in Ref. 2; AAH61727)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   239 AA;  26379 MW;  075A4ACBD581DB8C CRC64;
     MAPNALAPEP EHPEGIRAVL LGPPGAGKGT QAPKLAENFC VCHLATGDML RAMVASGSEL
     GKKLKATMDA GKLVSDEMVV ELIEKNLETP SCKNGFLLDG FPRTVKQAEM LDDLMDKRKE
     KLDSVIEFSI QDSLLIRRIT GRLIHPKSGR SYHEEFNPPK EAMKDDITGE PLIRRSDDNE
     KALKTRLEAY HTQTTPLVEY YRKRGIHCAI DASQTPDVVF ASILAAFSKA TCKDLVMFV
//
